Automatic Glucose Control During Meals and Exercise in Type 1 Diabetes: Proof-of-Concept in Silico Tests Using a Switched LPV Approach

Keeping the blood glucose levels within the safe range during meals and exercise still represents a major hurdle not only for patients with type 1 diabetes (T1D), but also for Artificial Pancreas (AP) systems. One of the reasons a fully (autonomous) closed-loop solution has not been released onto the market yet is the slow action of current insulin analogs. To partially overcome this limitation, the authors have previously designed a switched control strategy equipped with an insulin-on-board (IOB) safety loop that mitigates meal-related glucose excursions without carbohydrate counting. In this letter, a similar strategy based on a Linear Parameter-Varying (LPV) control law has been adapted to safely handle also exercise challenges with minimum user intervention. In silico results using the UVA/Padova simulator evidence that the proposed closed-loop scheme is feasible under moderate-intense exercise bouts by effectively and safely reducing the risk of hypoglycemia.

[1]  Eyal Dassau,et al.  Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise. , 2018, Diabetes technology & therapeutics.

[2]  Patricio Colmegna,et al.  Invalidation and low-order model set for artificial pancreas robust control design , 2019, Journal of Process Control.

[3]  K. Turksoy,et al.  Multivariable Artificial Pancreas for Various Exercise Types and Intensities. , 2018, Diabetes technology & therapeutics.

[4]  Eyal Dassau,et al.  Switched LPV Glucose Control in Type 1 Diabetes , 2016, IEEE Transactions on Biomedical Engineering.

[5]  G. Steil,et al.  Closed-loop insulin delivery-the path to physiological glucose control. , 2004, Advanced drug delivery reviews.

[6]  Emilia Fushimi,et al.  Automatic glycemic regulation for the pediatric population based on switched control and time-varying IOB constraints: an in silico study , 2020, Medical & Biological Engineering & Computing.

[7]  C. Cobelli,et al.  Physical Activity into the Meal Glucose—Insulin Model of Type 1 Diabetes: In Silico Studies , 2009, Journal of diabetes science and technology.

[8]  Hypoglycemia risk and glucose variability indices derived from routine self-monitoring of blood glucose are related to laboratory measures of insulin sensitivity and epinephrine counterregulation. , 2011, Diabetes technology & therapeutics.

[9]  Patricio Colmegna,et al.  Automatic regulatory control in type 1 diabetes without carbohydrate counting , 2018 .

[10]  Daniel Liberzon,et al.  Switching in Systems and Control , 2003, Systems & Control: Foundations & Applications.

[11]  Jorge Bondia,et al.  Detection and Control of Unannounced Exercise in the Artificial Pancreas Without Additional Physiological Signals , 2020, IEEE Journal of Biomedical and Health Informatics.

[12]  Patricio Colmegna,et al.  Linear parameter-varying model to design control laws for an artificial pancreas , 2018, Biomed. Signal Process. Control..

[13]  Marc D. Breton,et al.  Closed-Loop Control During Intense Prolonged Outdoor Exercise in Adolescents With Type 1 Diabetes: The Artificial Pancreas Ski Study , 2017, Diabetes Care.

[14]  B. Wayne Bequette,et al.  Challenges and recent progress in the development of a closed-loop artificial pancreas , 2012, Annu. Rev. Control..

[15]  Eyal Dassau,et al.  International Consensus on Use of Continuous Glucose Monitoring , 2017, Diabetes Care.

[16]  Eyal Dassau,et al.  Reducing Glucose Variability Due to Meals and Postprandial Exercise in T1DM Using Switched LPV Control , 2016, Journal of diabetes science and technology.

[17]  Eyal Dassau,et al.  Outpatient Closed-Loop Control with Unannounced Moderate Exercise in Adolescents Using Zone Model Predictive Control. , 2017, Diabetes technology & therapeutics.

[18]  H. De Battista,et al.  Safety Auxiliary Feedback Element for the Artificial Pancreas in Type 1 Diabetes , 2013, IEEE Transactions on Biomedical Engineering.

[19]  R. Rabasa-Lhoret,et al.  Artificial Pancreas Systems and Physical Activity in Patients with Type 1 Diabetes: Challenges, Adopted Approaches, and Future Perspectives , 2019, Journal of diabetes science and technology.

[20]  Patricio Colmegna,et al.  Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses , 2018, Journal of diabetes science and technology.

[21]  F. Doyle,et al.  Detection of a Meal Using Continuous Glucose Monitoring , 2008, Diabetes Care.

[22]  Graham C. Goodwin,et al.  A systematic stochastic design strategy achieving an optimal tradeoff between peak BGL and probability of hypoglycaemic events for individuals having type 1 diabetes mellitus , 2020, Biomed. Signal Process. Control..

[23]  Patricio Colmegna,et al.  Control-Oriented Model With Intra-Patient Variations for an Artificial Pancreas , 2020, IEEE Journal of Biomedical and Health Informatics.

[24]  M. Breton,et al.  In Silico Analysis of an Exercise-Safe Artificial Pancreas With Multistage Model Predictive Control and Insulin Safety System , 2019, Journal of diabetes science and technology.

[25]  Claudio Cobelli,et al.  Modeling Subcutaneous Absorption of Fast-Acting Insulin in Type 1 Diabetes , 2018, IEEE Transactions on Biomedical Engineering.

[26]  Francesca Annan,et al.  Exercise management in type 1 diabetes: a consensus statement. , 2017, The lancet. Diabetes & endocrinology.

[27]  K. Hunt,et al.  Identification of heart rate dynamics during moderate-to-vigorous treadmill exercise , 2015, BioMedical Engineering OnLine.